1. Home
  2. RVLV vs LIMNW Comparison

RVLV vs LIMNW Comparison

Compare RVLV & LIMNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVLV
  • LIMNW
  • Stock Information
  • Founded
  • RVLV 2003
  • LIMNW N/A
  • Country
  • RVLV United States
  • LIMNW United States
  • Employees
  • RVLV N/A
  • LIMNW N/A
  • Industry
  • RVLV Catalog/Specialty Distribution
  • LIMNW
  • Sector
  • RVLV Consumer Discretionary
  • LIMNW
  • Exchange
  • RVLV Nasdaq
  • LIMNW Nasdaq
  • Market Cap
  • RVLV N/A
  • LIMNW N/A
  • IPO Year
  • RVLV 2019
  • LIMNW N/A
  • Fundamental
  • Price
  • RVLV $20.44
  • LIMNW $0.30
  • Analyst Decision
  • RVLV Buy
  • LIMNW
  • Analyst Count
  • RVLV 15
  • LIMNW 0
  • Target Price
  • RVLV $26.20
  • LIMNW N/A
  • AVG Volume (30 Days)
  • RVLV 1.3M
  • LIMNW N/A
  • Earning Date
  • RVLV 08-05-2025
  • LIMNW N/A
  • Dividend Yield
  • RVLV N/A
  • LIMNW N/A
  • EPS Growth
  • RVLV 106.68
  • LIMNW N/A
  • EPS
  • RVLV 0.71
  • LIMNW N/A
  • Revenue
  • RVLV $1,156,039,000.00
  • LIMNW N/A
  • Revenue This Year
  • RVLV $7.71
  • LIMNW N/A
  • Revenue Next Year
  • RVLV $7.64
  • LIMNW N/A
  • P/E Ratio
  • RVLV $28.97
  • LIMNW N/A
  • Revenue Growth
  • RVLV 9.09
  • LIMNW N/A
  • 52 Week Low
  • RVLV $14.88
  • LIMNW N/A
  • 52 Week High
  • RVLV $39.58
  • LIMNW N/A
  • Technical
  • Relative Strength Index (RSI)
  • RVLV 47.22
  • LIMNW N/A
  • Support Level
  • RVLV $19.87
  • LIMNW N/A
  • Resistance Level
  • RVLV $21.37
  • LIMNW N/A
  • Average True Range (ATR)
  • RVLV 0.95
  • LIMNW 0.00
  • MACD
  • RVLV -0.13
  • LIMNW 0.00
  • Stochastic Oscillator
  • RVLV 16.96
  • LIMNW 0.00

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: